Terumo Blood and Cell Technologies has partnered with GenCure (a subsidiary of BioBridge Global) to expand and combine cell and gene therapy production solutions. Apheresis services firm Terumo and manufacturing services company for cell and cell-based advanced therapies GenCure said the partnership aims to link the cell and gene therapy (CGT) supply chain from end-to-end to find solutions to scale-up and quality challenges in the industry. This latest agreement follows a string of activities between the organizations dating back over…

Cytiva and Bayer have partnered to develop what they claim is the first modular end-to-end manufacturing platform for allogenic cell therapies. The multi-year development deal, of which no financial details have been disclosed, is already underway and aims to deliver production solutions to meet industry demands. Cytiva and Bayer say that this partnership will help to establish industry standards for manufacturing through their shared vision of a modular allogenic cell therapy manufacturing platform. The end goal is to accelerate speed…